Cilostazol is a phosphodiesterase III inhibitor with antiplatelet and vasodilatory properties, used mainly to treat intermittent claudication. It is grouped under the following drug class(es): Antiplatelets and Antithrombotic agents. Its therapeutic use is listed as hematologic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pletal, Cilostazolum and Pletaal. Its PubChem CID is 2754.
Cilostazol
| CAS No | 73963-72-1 |
|---|---|
| Molecular Formula | C20H27N5O2 |
| Molecular Weight | 369.5 g/mol |
| Synonyms | 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Cilostazol is a phosphodiesterase III inhibitor with antiplatelet and vasodilatory properties, used mainly to treat intermittent claudication. It is grouped under the following drug class(es): Antiplatelets and Antithrombotic agents.
The listed CAS number is 73963-72-1.
The listed molecular formula is C20H27N5O2.
The listed molecular weight is 369.5 g/mol.
6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one.
The source lists Pletal, Cilostazolum and Pletaal.